These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38709664)

  • 21. Difficult-to-treat and severe asthma in general practice: delivery and evaluation of an educational program.
    Hains I; Meyers J; Sterling K; Yoo J; Reddel H; Weston C
    BMC Fam Pract; 2019 Jul; 20(1):99. PubMed ID: 31301742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy for asthma.
    Fortescue R; Kew KM; Leung MST
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
    Chipps BE; Haselkorn T; Paknis B; Ortiz B; Bleecker ER; Kianifard F; Foreman AJ; Szefler SJ; Zeiger RS;
    J Allergy Clin Immunol; 2018 May; 141(5):1590-1597.e9. PubMed ID: 28797732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions to improve adherence to inhaled steroids for asthma.
    Normansell R; Kew KM; Stovold E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012226. PubMed ID: 28417456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
    Gibson PG; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Marks GB; Baraket M; Powell H; Taylor SL; Leong LEX; Rogers GB; Simpson JL
    Lancet; 2017 Aug; 390(10095):659-668. PubMed ID: 28687413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
    Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
    J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrolides versus placebo for chronic asthma.
    Undela K; Goldsmith L; Kew KM; Ferrara G
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD002997. PubMed ID: 34807989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between asthma/chronic obstructive pulmonary disease overlap syndrome and healthcare utilization among the US adult population.
    Kim M; Tillis W; Patel P; Davis RM; Asche CV
    Curr Med Res Opin; 2019 Jul; 35(7):1191-1196. PubMed ID: 30612470
    [No Abstract]   [Full Text] [Related]  

  • 36. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
    Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
    Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.
    Gallagher A; Edwards M; Nair P; Drew S; Vyas A; Sharma R; Marsden PA; Wang R; Evans DJ
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012929. PubMed ID: 34664263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis.
    Wark PAB; Hew M; Xu Y; Ghisla C; Nguyen TM; Erdemli B; Samant A; Nan C
    J Asthma; 2023 Apr; 60(4):727-736. PubMed ID: 35844195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.